Hobohm, Lukas http://orcid.org/0000-0002-4312-0366
Farmakis, Ioannis T.
Keller, Karsten
Scibior, Barbara
Mavromanoli, Anna C.
Sagoschen, Ingo
Münzel, Thomas
Ahrens, Ingo
Konstantinides, Stavros
Funding for this research was provided by:
Universitätsmedizin der Johannes Gutenberg-Universität Mainz
Article History
Received: 28 April 2022
Accepted: 29 July 2022
First Online: 17 August 2022
Declarations
:
: L. Hobohm reports lecture/consultant fees from MSD and Janssen, outside the submitted work. I.T. Farmakis reports no conflicts of interest. K. Keller reports no conflicts of interest. B. Scibior reports no conflicts of interest. A. Mavromanoli reports no conflicts of interest. I. Sagoschen reports no conflicts of interest. T. Münzel reports no conflict of interest. I. Ahrens reports personal lecture fees from Bayer Vital, Daiichi-Sankyo, Bristol-Meyers-Squibb, Pfizer and Boehringer. S.V. Konstantinides reports institutional grants and personal lecture/consultant fees from Bayer AG, Daiichi-Sankyo, and Boston Scientific; and personal lecture/consultant fees from Pfizer-Bristol-Myers Squibb and MSD, all outside the submitted work.